missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Beclin 1 Antibody, DyLight 650, Novus Biologicals™
Rabbit Polyclonal Antibody
Brand: Novus Biologicals NB110-87318C
This item is not returnable.
View return policy
Description
Beclin 1 Polyclonal specifically detects Beclin 1 in Human, Mouse, Rat, Porcine, Alligator, Canine, Primate samples. It is validated for Western Blot, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin, Knockdown Validated.
Specifications
| Beclin 1 | |
| Polyclonal | |
| Western Blot, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin, KnockDown Validated | |
| Q14457 | |
| BECN1 | |
| Synthetic peptide made to an internal portion of human Beclin 1 (within residues 150-300). [Swiss-Prot: Q14457] | |
| Affinity Purified | |
| RUO | |
| Primary | |
| Human, mouse, rat (96%), monkey, bovine (97%), porcine. Canine reactivity reported in scientific literature (PMID: 24027311). Possible reactivity to Chicken (87%), Xenopus laevis (79%), and Xenopus tropicalis (77%) (not yet validated). | |
| Store at 4C in the dark. |
| Western Blot, Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunohistochemistry (Paraffin), KnockDown | |
| DyLight 650 | |
| 50mM Sodium Borate with 0.05% Sodium Azide | |
| ATG6, ATG6 autophagy related 6 homolog, beclin 1 (coiled-coil, moesin-like BCL2 interacting protein), beclin 1 (coiled-coil, moesin-like BCL2-interacting protein), beclin 1, autophagy related, beclin1, beclin-1, Coiled-coil myosin-like BCL2-interacting protein, GT197, Protein GT197, VPS30 | |
| Rabbit | |
| 51 kDa | |
| 0.05 mL | |
| Apoptosis, Autophagy, Cancer, Hypoxia, Immunology, Innate Immunity, Tumor Suppressors | |
| 8678 | |
| Human, Mouse, Rat, Pig, Alligator, Canine, Primate | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction